California Law Summary - CPJE Review

These flashcards provide a comprehensive review of the California Law Summary for the CPJE, focusing on pharmacy regulations, licensure, operational standards, and federal drug laws as of the 2025 Edition.

CPJE Questions Composition

A total of 90 multiple-choice questions, including 75 scored test questions and 15 nonscored pretest items.

California State Board of Pharmacy Membership

Consists of 13 members: seven competent pharmacists appointed by the Governor, four public members, and representatives from Senate and Assembly.

Board of Pharmacy Highest Priority

The protection of the public shall be paramount and the highest priority in exercising licensing, regulatory, and disciplinary functions.

Orders of Correction Requests

A licensee may submit a written request for an office conference to contest an order within 30 days of service.

Pharmacist Licensure Age Requirement

An applicant must be at least $18$ years old.

Pharmacist-in-Charge (PIC) Driving Distance

If a pharmacist is the PIC for two pharmacies, they must not be separated by a driving distance of more than $50\,\text{miles}$.

Temporary Pharmacist-in-Charge

A pharmacy may designate a temporary PIC for a period not to exceed $120\,\text{days}$.

Pharmacist CE Requirements

Successfully complete $30\,\text{hours}$ of approved continuing pharmacy education every 2-year license period, except for the first renewal.

Intern Pharmacist Supervision Ratio

A pharmacist may not supervise more than $2$ interns at one time.

Community Pharmacy Technician Ratio

$1$ technician for the first pharmacist, and $2$ technicians for each additional pharmacist ($1:1$, then $2:1$).

License Reinstatement (Revoked License)

A person may petition for reinstatement after at least $3\,\text{years}$ from the effective date of the decision.

Pharmacist Consultation Requirement

Must be provided orally whenever there is a new prescription or upon request; written notice is required if the patient is not present or if shipped by mail.

Medication Error Investigation Timeline

An investigation must be initiated within $2\,\text{business days}$ from the date the error is discovered.

QA Review Record Retention

Quality assurance review records must be stored for at least $1\,\text{year}$ from the date they were created.

90-Day Drug Supply Requirements

Allowed for non-controlled drugs if the patient has completed an initial $30\,\text{day}$ supply and the prescriber did not indicate 'No change to quantity'.

Prescription Record Retention (Community vs. Hospital)

Community pharmacy records must be kept for at least $3\,\text{years}$; hospital chart orders for controlled substances must be maintained for $7\,\text{years}$.

CURES Program

The Controlled Utilization Review and Evaluation System used to track Schedule II, III, and IV prescriptions to reduce drug diversion.

Plan B (Emergency Contraception) Age

Available OTC to patients $17\,\text{years}$ or older; patients under $17$ require a prescription.

Compounded Non-aqueous Formulation BUD

The beyond-use date shall not exceed $180\,\text{days}$ or an extended date established by pharmacist research.

Compounded Water-containing Oral Formulation BUD

The beyond-use date shall not exceed $14\,\text{days}$ under refrigerated conditions or an extended date based on research.

ISO Class 8

The minimum required air quality for an Ante-area adjacent to sterile compounding.

Schedule II Oral Order (Emergency)

A pharmacist may dispense up to a $72\text{-hour}$ supply in an emergency, but the prescriber must provide a written or electronic order within $7\,\text{days}$.

DEA Form 222

The triplicate order form or electronic equivalent (CSOS) used for the purchase or transfer of Schedule II medications.

DEA Form 106

Used for reporting the theft or significant loss of a controlled substance.

Pseudoephedrine Sales Limits

Maximum of $3.6\,\text{g}$ per calendar day and $9\,\text{g}$ per $30\,\text{days}$ ($7.5\,\text{g}$ for mail order).

Poison Prevention Packaging Act (PPPA) Statistics

Child-resistant packaging must be resistant to $80\%$ of children under 5 and accessible to $90\%$ of adults within $5\,\text{minutes}$.

Drug Recall Class I

The highest level of recall for products that could cause serious harm or prove fatal.

Medicare Part D

The outpatient dispensing pharmacy benefit plan for prescription drugs.

Adulteration (Definition)

When a drug does not meet FDA standards in quality, strength, or purity (e.g., damaged by fire or mold).

Misbranding (Definition)

When labeling is erroneous, inadequate, or misleading (e.g., wrong drug name on label or missing strength).

Narrow Therapeutic Index (NTI) Drugs

Drugs with less than a two-fold difference between the median lethal dose and median effective dose (e.g., warfarin, lithium, digoxin).

USP 795

The chapter providing guidance on proper procedures for non-sterile compounding.

USP 800

Defines best practices for protecting healthcare workers and patients from exposure to hazardous drugs.

11159.2 Exemption

Allows a controlled substance prescription for a terminally ill patient to be written on a regular (non-security) prescription form.